) Oxidative stress is a state of reduction and oxidation (redox) imbalance caused by increased reactive oxygen species (ROS) generation, decreased antioxidant capacity, or both. Thus, it is important for cells to maintain a state of redox homeostasis by regulating the equilibrium between ROS production and scavenging capacity. Cancer cells are often exposed to intrinsic and extrinsic stresses that produce high levels of ROS and DNA damage. More importantly, we and others have shown that induction of oxidative stress is one of the underlying mechanisms of action for many anticancer drugs and radiation. Growing evidence has revealed that cancer stem cells (CSCs) play a critical role in therapy resistance and tumor relapse, as demonstrated by the fact that CSCs are selectively enriched in residual tumors following anticancer therapies. However, there is still an important gap in our knowledge of the mechanisms whereby CSCs maintain redox balance and counteract ionizing radiation (IR) and ROS-generating drug-induced oxidative stress. Our preliminary studies have demonstrated that CSCs are less responsive to IR and cisplatin-induced cell killing than non-stem cancer cells (NSCs) of human triple-negative breast cancer (TNBC). Moreover, we have found that ROS levels are significantly lower in CSCs than NSCs. These results suggest that CSCs have the capacity to maintain low levels of ROS and thus evade oxidative stress-induced toxicity. On the basis of these findings, we hypothesize that CSCs adopt a distinct redox signaling system to counteract oxidative stress and maintain lower levels of ROS, which consequently confers therapy-resistance to CSCs by overriding oxidative stress-induced cell death. Therefore, targeting of selective redox signaling pathways should sensitize therapy-resistant CSCs to ROS-generating anticancer drugs and radiotherapy.
Three specific Aims are proposed to test this hypothesis:
Aim 1 will define differences in redox signaling pathways between CSCs and NSCs;
Aim 2 will elucidate the mechanisms whereby CSCs maintain lower levels of ROS and self-renewal capacity;
and Aim 3 will determine if targeting of selective redox signaling pathways sensitizes therapy-resistant CSCs to chemotherapy and radiation. We anticipate the outcomes of this project will provide novel insights into the mechanisms whereby CSCs evade anticancer therapy-induced oxidative stress. New information obtained from this project will be essential to the development of innovative therapeutic strategies to eliminate therapy-resistant CSCs in human cancers and thus improve the efficacy of cancer treatment.

Public Health Relevance

Therapy resistance is a major roadblock to the success of current anticancer treatment and increasing evidence has recently shown that cancer stem cells (CSCs) are resistant to chemo- and radio-therapies. The goal of this project is to elucidate the mechanisms whereby CSCs evade anticancer therapy-induced oxidative stress. The results of this study will be essential to the development of innovative therapeutic strategies to eliminate therapy-resistant CSCs in human cancers and thus improve the efficacy of cancer treatment.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-RCB-6 (C2))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Medical University of South Carolina
United States
Zip Code
Nunes, Shirleide Santos; Fernandes, Renata Salgado; Cavalcante, Carolina Henriques et al. (2018) Influence of PEG coating on the biodistribution and tumor accumulation of pH-sensitive liposomes. Drug Deliv Transl Res :
Monteiro, Liziane O F; Fernandes, Renata S; Oda, Caroline M R et al. (2018) Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study. Biomed Pharmacother 97:489-495
Womersley, Jacqueline S; Townsend, Danyelle M; Kalivas, Peter W et al. (2018) Targeting redox regulation to treat substance use disorder using N-acetylcysteine. Eur J Neurosci :
Herr, Daniel J; Baarine, Mauhamad; Aune, Sverre E et al. (2018) HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury. J Mol Cell Cardiol 114:309-319
Angel, Peggi M; Comte-Walters, Susana; Ball, Lauren E et al. (2018) Mapping Extracellular Matrix Proteins in Formalin-Fixed, Paraffin-Embedded Tissues by MALDI Imaging Mass Spectrometry. J Proteome Res 17:635-646
Hedges, David M; Obray, J Daniel; Yorgason, Jordan T et al. (2018) Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway. Neuropsychopharmacology 43:1405-1414
Ramshesh, Venkat K; Lemasters, John J (2018) Imaging of Mitochondrial pH Using SNARF-1. Methods Mol Biol 1782:351-356
DeHart, David N; Lemasters, John J; Maldonado, Eduardo N (2018) Erastin-Like Anti-Warburg Agents Prevent Mitochondrial Depolarization Induced by Free Tubulin and Decrease Lactate Formation in Cancer Cells. SLAS Discov 23:23-33
Mazza, Alberto; Lenti, Salvatore; Schiavon, Laura et al. (2018) Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome. Biomed Pharmacother 105:992-996
Fernandes, Renata S; Silva, Juliana O; Seabra, HeloĆ­sa A et al. (2018) ?- Tocopherol succinate loaded nano-structed lipid carriers improves antitumor activity of doxorubicin in breast cancer models in vivo. Biomed Pharmacother 103:1348-1354

Showing the most recent 10 out of 109 publications